CEO Total Pay
$127K
FY2023 Summary Compensation, below median
CDMO FY2023 SEC EDGAR DEF 14A
Avid Bioservices, Inc. CEO pay ratio
The CEO earned $127K in FY2023 against median worker pay of $126,552 · Chemicals & Pharmaceuticals.
- State
- DE
- Filing date
- 2024-08-28
- Industry
- Chemicals & Pharmaceuticals
- Fiscal year
- FY2023
Data updated August 2026
Subscribe to Avid Bioservices, Inc. CEO pay filing updates (RSS)
CEO-to-worker pay ratio
35:1
Below Average (Scale: 0–1000:1)
CEO pay
$127K
Median worker
$126,552
Latest filing FY2023. This company's newest DEF 14A on file is for FY2023, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.
Answer first
Avid Bioservices, Inc. reported a 35:1 CEO-to-worker pay ratio in FY2023 - at or below the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.
Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.
- Pay ratio
- 35:1
- FY2023 disclosed
- CEO total
- $127K
- Summary Compensation Table total
- Median worker
- $126,552
- Dodd-Frank median employee
Ratio bands among Chemicals & Pharmaceuticals peers
Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.
CEO Compensation Breakdown, FY2023
A component-level pay breakdown is not reported in Avid Bioservices, Inc.'s structured SEC pay-ratio disclosure. See our methodology →
Filing-year trail · Avid Bioservices, Inc.
Complete DEF 14A pay-ratio filings for this CIK across FY2021–2023. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
- Latest ratio
- 35:1
- FY2023
- vs prior FY
- -27:1
- from FY2022 62:1
- CEO $ YoY
- +21%
- $127K latest
- Filings shown
- 3
- FY2021–2023
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2021 | $6.2M | - | $66,197 | 65:1 | - |
| 2022 | $105K | -98% | $104,595 | 62:1 | -3:1 |
| 2023 | $127K | +21% | $126,552 | 35:1 | -27:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 704562, FY2021–2023. Adjacent-year deltas only.
Industry Comparison - Chemicals & Pharmaceuticals
This Company's Ratio
35:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$127K
Companies in Industry
168
vs. Industry Median
Below
Avid Bioservices, Inc.: MODEST · MICRO pay ratio
Avid Bioservices, Inc. disclosed 35:1 CEO-to-worker pay and $127K CEO total in FY2023. the CEO earned 35× the median employee ($126,552) in FY2023.
Median employee $126,552 (ELITE-MED); MODEST · MICRO stamps put about 35 median-wage years per CEO year.
Pay Ratio
35:1
Below typical
What FY2023 shows for Avid Bioservices, Inc.
Avid Bioservices, Inc. disclosed 35:1 CEO-to-worker pay and $127K CEO total in FY2023. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Avid Bioservices, Inc.'s $127K CEO total is at or below the $7.9M industry median CEO pay.
Avid Bioservices, Inc. stamps MODEST · MICRO · ELITE-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.
Key Data, FY2023
- Total Compensation
- $127K
- Median Employee Pay
- $126,552
- Pay Ratio
- 35:1
- Filing Date
- 2024-08-28
Company Info
- Ticker
- CDMO
- CIK
- 704562
- Industry
- Chemicals & Pharmaceuticals
- SIC Code
- 2834
- State
- DE
SEC EDGAR DEF 14A for CIK 704562, FY2023. Informational only, not investment advice. Verify on EDGAR.
Read our methodology - how this data is sourced, computed, and verified. Avid Bioservices, Inc. disclosed 35:1 CEO-to-worker pay and $127K CEO total in FY2023.
Read with Avid Bioservices, Inc.
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · MICRO · ELITE-MED.
Cleveland-cliffs Inc. · MICRO
ABS(ceo_total_comp) peer at $127K (Δ $8 heavier vs Avid Bioservices, Inc.); STEEP · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Dynatrace, Inc. · MICRO
ABS(ceo_total_comp) peer at $126K (Δ $89 lighter vs Avid Bioservices, Inc.); MID · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Raymond James Financial Inc · MICRO
ABS(ceo_total_comp) peer at $126K (Δ $452 lighter vs Avid Bioservices, Inc.); STEEP · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Noble Corp plc · MICRO
ABS(ceo_total_comp) peer at $126K (Δ $578 lighter vs Avid Bioservices, Inc.); MID · ELITE-MED vs this page's MODEST · MICRO · ELITE-MED.
Chemicals & Pharmaceuticals benchmark
Avid Bioservices, Inc. stamps MODEST · MICRO · ELITE-MED inside SIC 28 - open the industry median board after the ABS peers.
Pay-ratio rankings · MODEST
See where MODEST · MICRO packages sit on the national leaderboard after reading Avid Bioservices, Inc..
Ratio primer · MODEST
Avid Bioservices, Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Avid Bioservices, Inc. (CIK 704562), FY2023. See our methodology. Aggregated by PlainCEOPay as of August 2026.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.